Guangxiang Luo Selected Research

Guangxiang Luo Research Topics

Disease

22	Infections 08/2021 - 01/2003
6	Hepatocellular Carcinoma (Hepatoma) 04/2015 - 10/2003
4	Virus Diseases (Viral Diseases) 01/2013 - 06/2007
4	Hepatitis A (Hepatitis, Infectious) 09/2012 - 01/2003
3	Hepatitis C 04/2015 - 11/2011
2	COVID-19 01/2023 - 11/2021
2	Chronic Hepatitis B 01/2021 - 12/2018
1	Hepatitis B 01/2021
1	Zika Virus Infection 12/2018
1	Carcinogenesis 07/2015
1	End Stage Liver Disease 04/2015
1	Fibrosis (Cirrhosis) 04/2015
1	Tuberous Sclerosis (Bourneville's Disease) 02/2013
1	Chronic Hepatitis (Chronic Active Hepatitis) 08/2006
1	Severe Acute Respiratory Syndrome 07/2004
1	Hepatitis 01/2003
1	Human Influenza (Influenza) 12/2002

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 11/2021 - 10/2003
7	Apolipoproteins E (ApoE)IBA 01/2021 - 12/2007
6	Monoclonal AntibodiesIBA 01/2023 - 11/2005
6	Antiviral Agents (Antivirals)IBA 01/2021 - 08/2006
6	ApolipoproteinsIBA 01/2021 - 12/2009
5	VaccinesIBA 11/2021 - 11/2011
3	VLDL LipoproteinsIBA 01/2017 - 07/2015
3	Small Interfering RNA (siRNA)IBA 06/2016 - 07/2012
3	RNA (Ribonucleic Acid)IBA 01/2013 - 01/2003
2	LDL Receptors (LDL Receptor)IBA 01/2021 - 07/2012
2	Interferon-alpha (Interferon Alfa)IBA 08/2006 - 11/2005
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2023
1	AntigensIBA 11/2021
1	COVID-19 VaccinesIBA 11/2021
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 08/2021
1	Angiotensin-Converting Enzyme 2IBA 08/2021
1	TeaIBA 08/2021
1	Virus ReceptorsIBA 01/2021
1	sodium-bile acid cotransporterIBA 01/2021
1	Apolipoprotein C-I (Apolipoprotein C1)IBA 11/2018
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2017
1	PhosphatidylserinesIBA 01/2017
1	Liposomes (Liposome)IBA 01/2017
1	Apolipoprotein E3IBA 06/2016
1	Lipoproteins (Lipoprotein)IBA 06/2016
1	LDL Lipoproteins (beta Lipoproteins)IBA 06/2016
1	EnzymesIBA 04/2015
1	Heparin (Liquaemin)FDA LinkGeneric 04/2015
1	Heparitin Sulfate (Heparan Sulfate)IBA 04/2015
1	OligosaccharidesIBA 04/2015
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 04/2015
1	Protein Kinases (Protein Kinase)IBA 02/2013
1	Sirolimus (Rapamycin)FDA Link 02/2013
1	Adenosine Monophosphate (AMP)IBA 02/2013
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 02/2013
1	trans-sodium crocetinate (crocetin)IBA 02/2013
1	AMP-Activated Protein KinasesIBA 02/2013
1	Protein Isoforms (Isoforms)IBA 02/2013
1	Mechanistic Target of Rapamycin Complex 1IBA 02/2013
1	RNA Helicases (RNA Helicase)IBA 01/2013
1	MicroRNAs (MicroRNA)IBA 01/2013
1	Viral ProteinsIBA 09/2012
1	Claudin-1IBA 07/2012
1	Amino Acids FDA Link 07/2012
1	OccludinIBA 07/2012
1	Ribavirin (Virazole)FDA LinkGeneric 11/2011
1	InterferonsIBA 11/2011
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 11/2008
1	LipidsIBA 11/2008
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 06/2007
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 06/2007
1	Neutralizing AntibodiesIBA 01/2007
1	Viral Envelope ProteinsIBA 01/2007
1	EpitopesIBA 01/2007
1	Complementary DNA (cDNA)IBA 11/2005
1	Glycoproteins (Glycoprotein)IBA 11/2005
1	AntibodiesIBA 07/2004
1	DNA (Deoxyribonucleic Acid)IBA 01/2003
1	thiobenzamideIBA 12/2002
1	ThioamidesIBA 12/2002

Therapy/Procedure

2	Therapeutics 01/2009 - 08/2006
1	Liver Transplantation 04/2015